Company posted net profit of Rs 21 crore during the July-Sept quarter of the previous fiscal
Total income increased 14% to Rs 8,765 crore due to operations of all units at its Mundra and Maithon plants
Net sales of the company, however, rose marginally to Rs 495 crore during the second quarter
Profits fell because of higher expenditure that rose to Rs 187 crore during Q2
Company posted a net profit of Rs 148 crore for the corresponding period of previous fiscal
Forex losses and a delay in regulatory approvals led to the slump
Consolidated net profit stood at Rs 74.97 crore
Company sold 1,00,660 units in the corresponding period of 2012
This is the 8th consecutive quarter in which the company has reported loss on consolidated basis
However, the total income increased 5.5% to Rs 1,759 cr
The total income rose 9.6% during the same period to Rs 23,897 cr
A weak rupee and sales boost from products like Prandin, Doxil & Doxycycline led to such an extraordinary quarter
Net profit slumps 35%, but stock gains as pace of bad loan growth slows
Total income rises 12.5% to Rs 537 cr
Total income during quarter increased to Rs 757 cr
Total income jumps 23% to Rs 1,379 cr
Bank reports Rs 71 cr profit; however, total income up by 12% to Rs 3,175 cr
However, operating profit grew 17.29% to Rs 228 cr
HCL had clocked Rs 19 crore net profit in the first quarter of the current fiscal
In October, company sold 5,750 units, up 91%